# EDGAR Filing Document

**Accession Number:** 0001478069
**File Stem:** 0001193125-23-020405
**Filing Date:** 2023-1
**Character Count:** 4586
**Document Hash:** b44e358f7b32fb389d8d57a3824166a0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-020405.hdr.sgml**: 20230131

**ACCESSION NUMBER**: 0001193125-23-020405

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230131

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CONTRAFECT Corp
- **CENTRAL INDEX KEY:** 0001478069
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36577
- **FILM NUMBER:** 23572973

**BUSINESS ADDRESS:**
- **STREET 1:** 28 WELLS AVENUE
- **STREET 2:** 3RD FLOOR
- **CITY:** YONKERS
- **STATE:** NY
- **ZIP:** 10701
- **BUSINESS PHONE:** 914-207-2300

**MAIL ADDRESS:**
- **STREET 1:** 28 WELLS AVENUE
- **STREET 2:** 3RD FLOOR
- **CITY:** YONKERS
- **STATE:** NY
- **ZIP:** 10701

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, DC 20549** 

------

**SCHEDULE 14A** 

**(RULE 14a-101)** 

**INFORMATION REQUIRED IN PROXY STATEMENT** 

**SCHEDULE 14A INFORMATION** 

**Proxy Statement Pursuant to Section 14(a) of the** 

**Securities Exchange Act of 1934** 

------

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** 

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

**CONTRAFECT CORPORATION** 

**(Name of Registrant as Specified In Its Charter)** 

**(Name of Person(s) Filing Proxy Statement, if Other than Registrant)** 

Payment of Filing Fee (check all boxes that apply):

☒ No fee required

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

**CONTRAFECT CORPORATION** 

**28 WELLS AVENUE, THIRD FLOOR** 

**YONKERS, NEW YORK 10701** 

**ContraFect Announces Adjournment of Special Meeting of Stockholders** 

**with Respect to Reverse Stock Split Proposal** 

ContraFect Corporation (the "Company") announced that today it convened its Special Meeting of Stockholders ("Special Meeting") as scheduled for January 31, 2023 and considered all items of business with the exception of Proposal 1, the proposed amendments to its certificate of incorporation to effect a reverse stock split as set forth in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on January 3, 2023 (the "Reverse Stock Split Proposal"). At the Special Meeting, stockholders approved an adjournment of the Special Meeting to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal or another proposal pertaining to the issuance of the Company's common stock under Nasdaq Listing Rule 5635(d).

Consequently, the Special Meeting was adjourned with respect to the Reverse Stock Split Proposal. The Special Meeting will be reconvened on February 10, 2023 at 9:00 am ET (the "Reconvened Special Meeting"). The sole matter of business before the Reconvened Special Meeting will be the Reverse Stock Split Proposal. The Company believes that allowing additional time for stockholders to vote is in the interest of stockholders.

The Company will continue to solicit proxies from stockholders with respect to the Reverse Stock Split Proposal, and electronic voting platforms are expected to remain open. The Board recommends that stockholders vote "FOR" the Reverse Stock Split Proposal. The Record Date for determining stockholders eligible to vote on the Reverse Stock Split Proposal remains December 22, 2022.

The Company encourages any eligible stockholder that has not yet voted their shares or provided voting instructions to their broker or other record holders on the Reverse Stock Split Proposal to do so promptly. If a stockholder has previously submitted its proxy and does not wish to change its vote with respect to the Reverse Stock Split Proposal, no further action is required. Stockholders who need help voting their shares may call the Company's proxy solicitor, Georgeson LLC at (866) 729-6811.

The Company expects to file the voting results regarding the other proposals considered at the Special Meeting on a Form 8-K with the Securities and Exchange Commission within four business days of January 31, 2023.